Bearded Dragon Atadenovirus
Learn what the condition is, how it may be detected early, how it is treated or managed, and which breeds or species are linked to it.
Condition snapshot
A concise guide to the condition’s pattern, detection, management and urgency.
Separate positive dragonsUse dedicated equipment and do not mix positive animals with negative breeding stock; recovery does not prove shedding has ended.
This snapshot is a general guide, not a diagnosis or treatment plan. New, severe or worsening signs require veterinary assessment.
About the condition
Atadenovirus infection is well recognised in bearded dragons and may damage the liver, intestines and nervous system. Some infected animals remain carriers and shed virus intermittently.
Agamid atadenovirus is best known in bearded dragons and can cause severe disease in juveniles, although infected adults may remain outwardly healthy carriers. The virus targets liver, gastrointestinal and neurologic tissues, producing poor growth, weight loss, diarrhoea, weakness, abnormal posture, opisthotonos or sudden death. Coinfection with parasites or bacteria and the stress of sale, transport or crowding can worsen expression. Detection of viral DNA does not by itself predict whether a dragon will develop disease, but a positive animal can shed and expose breeding stock or juveniles. Transmission occurs through faecal contamination, close contact and shared equipment; infected parents may contribute to early exposure. The disease is not equivalent to adenovirus infections of other reptile groups, so the species and test target matter. A small juvenile that fails to thrive requires a broad evaluation because malnutrition, coccidiosis and husbandry errors can mimic the presentation.
Breeding collections, infected parents, shared equipment and stress increase transmission and clinical disease. Poor growth, chronic weakness, diarrhoea, weight loss, neurological signs and sudden death may occur, especially in juveniles.
Disease expression is strongly age- and condition-dependent: juveniles with limited reserves may diverge from clutch mates before a dramatic gastrointestinal or neurologic crisis occurs. Viral injury to liver and intestine can magnify the effects of parasites, poor nutrition and transport stress. Adults that remain productive and outwardly normal still matter epidemiologically because breeding and movement can introduce infection into new groups. A positive result therefore informs both individual care and collection planning. Breeding from a clinically normal positive animal can perpetuate infection in vulnerable offspring and new households.
Screening & Early Detection
Use a reptile-specific PCR on cloacal or faecal samples, repeating when suspicion remains because shedding and sample quality vary. Interpret a positive result with age, signs and collection history rather than calling every carrier clinically ill. Blood chemistry may show liver involvement, and faecal examination identifies common concurrent parasites. Necropsy with histopathology and tissue PCR is valuable after unexplained juvenile deaths. Test new breeding animals before introduction and maintain individual records so positive lineages and exposed clutches are not mixed unknowingly.
PCR testing of fresh faeces or cloacal samples can detect shedding, but results must be interpreted with clinical findings and repeated testing.
Use PCR on an appropriate cloacal, faecal or tissue sample and interpret it with age, clinical signs and liver or intestinal findings. Repeat sampling may be needed when exposure is strong but shedding is intermittent. Screen breeding animals and quarantine additions, and preserve tissues for histopathology and PCR after unexplained juvenile deaths. Growth failure in a juvenile is assessed against clutch mates and verified feeding because chronic viral disease may first appear as divergence from the group.
Treatment & Management
There is no specific cure. Supportive nutrition, treatment of secondary disease, stress reduction and strict separation are used. No antiviral treatment reliably clears atadenovirus. Support affected dragons with species-appropriate warmth and UVB, careful hydration and nutritionally balanced assisted feeding when they can digest safely. Treat documented coccidia, bacterial infection or liver complications without assuming they caused the entire syndrome. Minimise handling and other stress during recovery. House positive animals separately from negative breeding stock, use dedicated equipment and remove faeces promptly after physical cleaning. Repeated PCR may help assess shedding but cannot guarantee eradication or future noninfectivity. Do not breed clinically affected animals, and disclose positive status before any transfer. Juveniles with progressive neurologic or hepatic disease can have a poor prognosis, making serial weight, behaviour and quality-of-life assessment central to decisions.
No antiviral reliably clears atadenovirus. Support hydration, temperature, nutrition and treatment of documented secondary disease while minimising stress. Keep infected dragons separate from uninfected breeding groups and use dedicated equipment because clinical recovery does not establish freedom from shedding. Progressive wasting, seizures or inability to feed requires an explicit welfare assessment.
Carrier animals may remain stable, while clinically affected juveniles can have a poor prognosis.
